Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Duane Boise Interview "EXPOSE DEA"
16 Views • Jul 20, 2025
Description
— Duane Boise, CEO of MMJ International Holdings, on Cannabis Coast to Coast News (7/14/25)
🚨 In his explosive national interview, Duane Boise exposes the DEA’s ongoing sabotage of FDA-authorized medical cannabis research. Despite full regulatory compliance and millions invested in a pharmaceutical-grade facility, MMJ BioPharma has been blocked from launching its Huntington’s disease and MS trials—because the DEA refuses to issue a bulk manufacturing license.
🔥 Boise’s Highlights:
✅ “We followed every rule—but DEA weaponized the system against us.”
✅ “The DEA’s administrative process isn’t just broken—it’s unconstitutional.”
✅ “We’re filing a federal lawsuit to hold corrupt officials accountable and defend patient access.”
🧠MMJ’s mission: Advance pharmaceutical-grade cannabinoid drugs—not dispensary products—via FDA pathways, for diseases with no cure.
More from User
DEA ANNE MILGRAM EXPOSED
MMJ International Holdings
Duane Boise Interview "EXPOSE DEA"
MMJ International Holdings
DEA INTENTIONALLY BLOCKING CANNABIS RESEARCH
MMJ International Holdings
MARIJUANA JUDICIARY HEARING - DEA TERRANCE COLE
MMJ International Holdings
DEA IS THE EPITOME OF INEPTITUDE- MMJ CANABIS LITIGATION
MMJ International Holdings
MMJ International Huntington's Disease FDA Clinical Trial
MMJ International Holdings
Related Videos
DEA DELAYS DUANE BOISE & THE MMJ RESEARCH TEAM BUT BLACK MARKET THRIVES RIGHT UNDER THEIR NOSE
MMJ International Holdings
Duane Boise & MMJ Team DEA Approval imminent to grow marijuana
MMJ International Holdings
DEA - DUANE BOISE MMJ MARIJUANA RESEARCH DELAYS UNEXPLAINED AS MS AND HD PATIENTS CONTINUE TO SUFFER
MMJ International Holdings
Duane Boise MMJ Interview Benzinga Capital Cannabis Conference 2023
MMJ International Holdings
DUANE BOISE EMED CEO MEETS PRIME MINISTER JAMAICA
Emedevac
DUANE BOISE & MMJ TEAM -WHY MARIJUANA CLINICAL TRIALS
MMJ International Holdings